1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 54 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019Intragastric administration of the bitter tastant, quinine, lowers the glycemic response to a nutrient drink without slowing gastric emptying, in healthy men.Bitarafan, V.; Fitzgerald, P.C.; Little, T.J.; Meyerhof, W.; Jones, K.L.; Wu, T.; Horowitz, M.; Feinle-Bisset, C.
2019Longitudinal evaluation of gastric emptying in type 2 diabetesWatson, L.E.; Phillips, L.K.; Wu, T.; Bound, M.J.; Jones, K.L.; Horowitz, M.; Rayner, C.K.
2019A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: a 12-week, single-blind, randomized, placebo-controlled trialWatson, L.E.; Phillips, L.K.; Wu, T.; Bound, M.J.; Checklin, H.L.; Grivell, J.; Jones, K.L.; Clifton, P.M.; Horowitz, M.; Rayner, C.K.
2019Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetesJones, K.L.; Rigda, R.S.; Buttfield, M.D.M.; Hatzinikolas, S.; Pham, H.T.; Marathe, C.S.; Wu, T.; Lange, K.; Trahair, L.G.; Rayner, C.K.; Horowitz, M.
2014Changes in meal composition and duration affect postprandial endothelial function in healthy humansThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Jones, K.; Willoughby, S.; Horowitz, M.; Rayner, C.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2016Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: a randomised controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2016Regional specificity of the gut-incretin response to small intestinal glucose infusion in healthy older subjectsRigda, R.; Trahair, L.; Little, T.; Wu, T.; Standfield, S.; Feinle-Bisset, C.; Rayner, C.; Horowitz, M.; Jones, K.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.

Discover